Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis

• Main Authors: Wen-Chu Ye, Shi-Feng Huang, Lian-Jie Hou, Hai-Jiao Long, Kai Yin, Ching Yuan Hu, Guo-Jun Zhao
• Format: Article
• Language: English
• Published: Frontiers Media S.A. 2021-06-01
• Series: Frontiers in Cardiovascular Medicine
• Subjects: cholesterol homeostasis; lncRNAs; liver disease; lipid-related diseases; cardiovascular disease
• Online Access: https://www.frontiersin.org/articles/10.3389/fcvm.2021.688546/full

Maintaining cholesterol homeostasis is essential for normal cellular and systemic functions. Long non-coding RNAs (lncRNAs) represent a mechanism to fine-tune numerous biological processes by controlling gene expression. LncRNAs have emerged as important regulators in cholesterol homeostasis. Dysregulation of lncRNAs expression is associated with lipid-related diseases, suggesting that manipulating the lncRNAs expression could be a promising therapeutic approach to ameliorate liver disease progression and cardiovascular disease (CVD). However, given the high-abundant lncRNAs and the poor genetic conservation between species, much work is required to elucidate the specific role of lncRNAs in regulating cholesterol homeostasis. In this review, we highlighted the latest advances in the pivotal role and mechanism of lncRNAs in regulating cholesterol homeostasis. These findings provide novel insights into the underlying mechanisms of lncRNAs in lipid-related diseases and may offer potential therapeutic targets for treating lipid-related diseases.